CYBERMED NEWS - Higher Medical Scientifc Information and Research

CYBERMED NEWS

Low-dose arsenic killing most lethal type of brain cancer

Written by CYBERMED NEWS
facebook Share on Facebook

Poison is in the dose—as researchers have demonstrated yet again with the discovery that very low amounts of arsenic can combat one of the most aggressive forms of brain cancer.

Arsenic trioxide has been used for years to treat a rare type of blood cancer—but it can also combat the most aggressive and common form of brain cancer, gliobastoma multiforme.

 

The average life expectancy of the patient is just 15 months, but researchers from the Northwestern University Feinberg School of Medicine have discovered that arsenic can extend that by up to four times.

 

Arsenic's great advantage over most conventional cancer therapies is its ability to cross the blood-brain barrier—and it works better than every other therapy the researchers investigated. The researchers had looked at the cancer-fighting potential of more than 650 different compounds.

 

https://wddty.com/news/2017/10/low-dose-arsenic-killing-most-lethal-type-of-brain-cancer.html?utm_source=Boomtrain&utm_medium=email&utm_campaign=enews_24102017&bt_ee=m8lMFPJDIr3Okz1ceMk9UXSsA040t6zXoiobIv43w/VW219qAlX2OZFEwXwE/GU9&bt_ts=1508839811517


Related Articles

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.